The largest database of trusted experimental protocols

Immobilon p membrane based 96 well plates

Manufactured by Merck Group
Sourced in Morocco

Immobilon P membrane-based 96-well plates are laboratory equipment used for protein detection and analysis. The plates feature a polyvinylidene fluoride (PVDF) membrane that is pre-coated and ready to use. This membrane-based format allows for efficient protein capture and transfer for various immunoassay applications.

Automatically generated - may contain errors

2 protocols using immobilon p membrane based 96 well plates

1

Memory B Cell IgG Secretion ELISpot

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISpot assay of memory B cell IgG secretion was performed as previously described
25 (link). Immobilon P membrane-based 96-well plates (Millipore, Billerica, MA) were coated overnight at 4°C with 10
µg/mL H3N2 HA in phosphate-buffered saline (PBS) (40
µl/well). PBS only was added to the negative-control wells. Plates were blocked with complete PRMI 1640 medium. Cells were plated at a density of 10
6 per well in U-bottom plates and stimulated with CpG
2006 ODN, six days after stimulation with A/Vic11 (H3N2, IRR catalog No: FR-1041). B cells were resuspended in complete medium containing either alkaline phosphatase-conjugated goat anti-human IgG (H-L) (KPL, Gaithersburg, MD) at 0.2
µg/mL and incubated for 5h at 37°C in 5% CO
2. The plates were washed, and then HA antibody secreting cell spots were developed with an alkaline phosphatase substrate kit (Vector Laboratories, Burlingame, CA). Spots were counted using a CTL ImmunoSpot plate reader and counting software (Cellular Technology Limited, Cleveland, OH).
+ Open protocol
+ Expand
2

Quantifying Vaccine-Specific Antibody-Secreting Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
On days 6, 7, or 8 after each dose of H7N7 PLAIV in the first cohort (15 subjects), circulating IgG Antibody-secreting cells (ASCs) specific for the vaccine and the H7 HA were enumerated by ELISpot assay. The ELISpot assay was performed largely as described previously [21 (link)]. Immobilon P membrane-based 96-well plates (Millipore, Billerica, MA) were coated wi th β-propiolactone-inactivated vaccine virus diluted in PBS to 5000 HAU/ml or with recombinant H7 from A/Netherlands/219/2003 (H7N7) (BEI Resources) at 1 μg/ml. PBS only was added to negative control wells. Enriched B cells were resuspended in complete medium containing alkaline phosphatase-conjugated goat anti-human IgG (H + L) (KPL, Gaithersburg, MD) at .2 μg/ml. Serial 2-fold dilutions of the cell suspensions were prepared in coated and blocked plates and incubated overnight. After washing and spot development, spots were counted using a CTL ImmunoSpot plate reader and counting software (Cellular Technology Limited, Cleveland, OH). Spot counts are expressed as a frequency of input CDI 9+ cells. The enriched B cells were also characterized by flow cytometry as described previously [22 ].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!